Lifeward Ltd (LFWD) concluded trading on Thursday at a closing price of $1.60, with 102.82 million shares of worth about $164.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.42% during that period and on March 13, 2025 the price saw a gain of about 8.84%. Currently the company’s common shares owned by public are about 10.63M shares, out of which, 9.34M shares are available for trading.
Stock saw a price change of 1.27% in past 5 days and over the past one month there was a price change of -28.57%. Year-to-date (YTD), LFWD shares are showing a performance of -7.51% which decreased to -71.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.25 but also hit the highest price of $6.00 during that period. The average intraday trading volume for Lifeward Ltd shares is 835.22K. The stock is currently trading -6.21% below its 20-day simple moving average (SMA20), while that difference is down -7.16% for SMA50 and it goes to -42.67% lower than SMA200.
Lifeward Ltd (NASDAQ: LFWD) currently have 10.63M outstanding shares and institutions hold larger chunk of about 2.50% of that.
The stock has a current market capitalization of $17.01M and its 3Y-monthly beta is at 1.58. It has posted earnings per share of -$3.32 in the same period. It has Quick Ratio of 1.43 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LFWD, volatility over the week remained 28.70% while standing at 16.14% over the month.
Stock’s fiscal year EPS is expected to rise by 74.27% while it is estimated to increase by 131.52% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Laidlaw on February 10, 2025 offering a Buy rating for the stock and assigned a target price of $10 to it. Coverage by Barclays stated Lifeward Ltd (LFWD) stock as an Underweight in their note to investors on April 03, 2017, suggesting a price target of $1.50 for the stock. On December 16, 2016, Oppenheimer Initiated their recommendations, while on July 15, 2016, Piper Jaffray Initiated their ratings for the stock with a price target of $10. Stock get a Buy rating from Canaccord Genuity on May 22, 2015.
